Jillian Perry | Materials Science | Best Researcher Award

Assist Prof Dr. Jillian Perry | Materials Science | Best Researcher Award

University of North Carolina - Chapel Hill | United States

Author Profile

Google Scholar

🧠 Early Academic Pursuits

Assist. Prof. Dr. Jillian Perry's academic journey began with a Bachelor of Science in Chemical Engineering, awarded Cum Laude from the University of Florida in 2004, with a minor in Chemistry. Building on her solid foundation, she pursued a PhD in Biomedical Engineering at the same university, where she conducted pioneering research on chitosan nanotube synthesis for drug delivery applications. Her dissertation, supervised by Dr. John D. Steward and Dr. Charles R. Martin, laid the groundwork for a career focused on innovative solutions in drug delivery and nanotechnology.

💼 Professional Endeavors

Currently an Assistant Professor at the University of North Carolina’s Eshelman School of Pharmacy, Dr. Perry also contributes to the Center for Nanotechnology in Drug Delivery. Since joining UNC in 2010 as a Postdoctoral Research Associate at the Lineberger Comprehensive Cancer Center, she has been mentored by renowned researchers like Dr. Joseph M. DeSimone. Over the years, she progressed from a Research Associate Scientist to her current position, collaborating on high-impact research in pharmacoengineering and molecular pharmaceutics.

🧬 Contributions and Research Focus

Dr. Perry’s research explores 3D-printed microneedles, transdermal drug delivery systems, and nanoparticle-based cancer immunotherapies. She has authored numerous impactful publications, contributing extensively to fields such as tumor targeting and transdermal vaccination techniques. Her work includes significant studies on hydrogel-based cancer treatments and PRINT nanoparticle technology for enhanced therapeutic delivery.

🏆 Accolades and Recognition

Dr. Perry has been honored with several awards, such as the 2020 Junior Faculty Development Award and the NanoDDS Poster Award in 2018. Her 3D-printed vaccine patch technology received global attention and won the Fast Company’s World Changing Ideas Award in 2022. She was also recognized for her academic excellence with prestigious scholarships like the University Scholars Scholarship and Bright Futures Scholarship during her undergraduate years.

🌍 Impact and Influence

With an H-index of 19 and over 2,130 citations, Dr. Perry’s research has influenced the scientific community's understanding of nanomedicine and drug delivery technologies. Her innovative approaches in microneedle design and 3D printing for vaccine delivery have potential applications beyond academia, transforming practical healthcare delivery methods and advancing public health initiatives worldwide.

📜 Legacy and Future Contributions

As a thought leader in nanotechnology and biopharmaceuticals, Dr. Perry is expected to continue making groundbreaking contributions to transdermal vaccine development and targeted cancer therapies. Her active role in patenting novel drug delivery systems and designing biocompatible materials solidifies her legacy as a researcher committed to pioneering health solutions. Future contributions will likely include further advancements in non-invasive drug delivery and enhanced treatment efficacy in challenging medical fields, paving the way for transformative healthcare solutions.

 

Publications


📄  Development of 3D printed microneedles of varied needle geometries and lengths, designed to improve dermal delivery of topically applied psoriasis treatments

Authors: Pünnel LC, Palmtag M, Lunter DJ, Perry JL
Journal: European Journal of Pharmaceutics and Biopharmaceutics
Year: 2024


📄  3D-printed Lattice Microneedle Array Patches for Tunable and Versatile Intradermal Delivery

Authors: Rajesh NU, Hwang J, Xu Y, Saccone MA, Hung A, Hernandez RAS, Coates IA, Driskill MM, Dulay MT, Jacobson GB, Tian S, Perry JL#, DeSimone JM
Journal: Advanced Materials
 Year: 2024


📄  Development of a biocompatible 3D hydrogel scaffold using CLIP for the delivery of cell therapy to treat recurrent glioblastoma

Authors: Kass L, Morrent T, Zhang Y, DeVane C, Logan J, Tessema A, Perry JL#, Hingtgen SD
 Journal: Bioengineering and Translational Medicine
Year: 2024


📄  3D-Printed Microarray Patches for Transdermal Applications

Authors: Rajesh NU, Coates I, Driskill MM, Dulay MT, Hsiao K, Ilyn D, Jacobson GB, Kwak JW, Lawrence M, Perry JL, Shea CO, Tian SM, DeSimone JM
 Journal: JACS Au
 Year: 2022


📄  Transdermal Vaccination via 3D Printed Microneedles Induces Potent Humoral and Cellular Immunity

Authors: Caudill CL, Perry JL, Illiadis K, Tessema AT, Lee BJ, Mecham BS, Tian S, DeSimone JM
Journal: PNAS
 Year: 2021


 

Govindaraj Sabarees | Materials Science | Best Researcher Award

Dr. Govindaraj Sabarees | Materials Science | Best Researcher Award

Shri Venkateshwara College of Pharmacy | India

Author Profile

Orcid

Google Scholar

Early Academic Pursuits 🎓

Dr. Govindaraj Sabarees began his academic journey with a solid foundation in pharmacy. He earned his B. Pharmacy degree from Sankaralingam Bhuvaneshwari College of Pharmacy, Sivakasi, Tamil Nadu, achieving first-class honors. This was followed by an M. Pharmacy in Pharmaceutical Chemistry from C.L. Baid Metha College of Pharmacy, Chennai, where he also graduated with first-class distinction. His academic achievements laid the groundwork for his research-oriented career.

Professional Endeavors 🏢

Dr. Sabarees gained significant experience as a Bioanalytical Research Associate at Amaris Clinical, a division of Caplin Point Laboratories, Chennai. During this period, he honed his skills in bioanalytical methods, high-end equipment handling, and synthetic organic chemistry. His hands-on experience in these areas has contributed to his expertise in pharmaceutical research, particularly in the development and validation of analytical methods.

Contributions and Research Focus 🔬

Dr. Sabarees has made substantial contributions to pharmaceutical research, particularly in the field of wound healing and molecular docking. His research includes the discovery of curcumin analogs as potential wound healing agents and the development of novel electrospun nanofibers for biomedical applications. His work has been widely published in reputable journals, showcasing his ability to bridge the gap between theoretical research and practical applications in medicine.

Accolades and Recognition 🏆

Throughout his career, Dr. Sabarees has received recognition for his contributions to pharmaceutical research. His participation in various national and international conferences, where he has presented his findings, has earned him a respected place in the academic and research community. His publications in high-impact journals further underscore his commitment to advancing the field of pharmaceutical sciences.

Impact and Influence 🌍

Dr. Sabarees's research has had a significant impact on the development of new therapeutic agents and materials, particularly in the area of wound management. His work on molecular docking and dynamics simulations has opened new avenues for drug discovery and development. His influence extends to his role as a mentor and educator, where he has guided junior researchers and pharmacy students, helping shape the next generation of pharmaceutical scientists.

Legacy and Future Contributions 🌟

As Dr. Sabarees continues to advance in his career, his ongoing research and future projects promise to make lasting contributions to the field of pharmaceutical sciences. His work on electrospun nanofibers and molecular docking is likely to lead to new breakthroughs in drug delivery systems and therapeutic materials. Dr. Sabarees's legacy will be one of innovation, dedication, and a commitment to improving healthcare outcomes through cutting-edge research.

 

Publications


  • 📖 Fabrication of Quercetin-Functionalized Morpholine and Pyridine Motifs-Laden Silk Fibroin Nanofibers for Effective Wound Healing in Preclinical Study
    Authors: Govindaraj Sabarees, Vadivel Velmurugan, Siddan Gouthaman, Viswas Raja Solomon, Subramani Kandhasamy
    Journal: Pharmaceutics
    Year: 2024

  • 📖 Advances in Electrospun Chitosan Nanofiber Biomaterials for Biomedical Applications
    Authors: Ganesan Padmini Tamilarasi, Manikandan Krishnan, Govindaraj Sabarees, S. Gouthaman, Alagarsamy Veerchamy, Viswas Raja Solomon
    Journal: Materials Advances
    Year: 2023

  • 📖 Discovery of new naphthyridine hybrids against enoyl-ACP reductase (inhA) protein target of Mycobacterium tuberculosis: Molecular docking, molecular dynamics simulations studies
    Authors: Govindaraj Sabarees, Vadivel Velmurugan, Viswas Raja Solomon
    Journal: Chemical Physics Impact
    Year: 2023

  • 📖 Recent Trends in Electrospun Antibacterial Nanofibers for Chronic Wound Management
    Authors: Ganesan Padmini Tamilarasi, Govindaraj Sabarees, Krishnan Manikandan, Siddan Gouthaman, Veerachamy Alagarsamy, Viswas Raja Solomon
    Journal: Current Nanomedicine
    Year: 2023

  • 📖Recent Developments in Electrospun Nanofibers as Delivery of Phytoconstituents for Wound Healing
    Authors: Govindaraj Ajith, Ganesan Padmini Tamilarasi, Govindaraj Sabarees, Siddan Gouthaman, Krishnan Manikandan, Vadivel Velmurugan, Veerachamy Alagarsamy, Viswas Raja Solomon
    Journal: Drugs and Drug Candidates
    Year: 2023